King’s College London Prostate cancer treatment study shows percentage of men who had a...
A study co-led by researchers at King’s College London shows that the percentage of men...
Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2...
Abbott and Enanta Pharmaceuticals today announced 12-week results from a Phase 2 study of...
Cytheris announces results of phase IIa study indicating that recombinant interleukin-7 (CYT107)
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies...
New potential drug targets discovered for preventing prostate cancer cell growth
Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered...
Progenics Reports Positive Preliminary Data from Ongoing Phase 1 Clinical Study of PSMA ADC
Progenics Pharmaceuticals, Inc.reported positive preliminary data from an ongoing phase 1 study of PSMA ADC,...
Manhattan Research’s ePharma Consumer study provides in-depth info about pharma product websites
Pharmaceutical and healthcare market research company Manhattan Research recently released the ePharma Consumer® v10.0 study,...
Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b study of RDEA594...
Pro-Pharmaceuticals and Mount Sinai annouced New Liver Fibrosis Research Collaboration
Pro-Pharmaceuticals, Inc., the leading developer of Galectin therapeutics to treat cancer and fibrosis, today announced...
New data show potential for Novartis Meningitis B vaccine candidate to cover majority of...
New data demonstrated that antibodies induced by Novartis Vaccines investigational, four component, Meningococcal Serogroup B...
University of Rochester Spearheads FDA Initiative to Speed Development of New Therapies
Pain is the most common symptom leading patients to see a physician in the United...
